News

The wave of GMOs/NGTs (new genomic techniques) is promised by US and European multinationals, and promoted by the European Commission and agricultural lobbies. But it also raises intellectual property issues for some « intermediate » seed companies. These GMOs/NGTs are in fact protected by patents with a potentially very broad scope, which can have an impact on […]

The European Commission claims that its proposal for deregulation, which it put forward on July 5 2023, does not concern all GMOs but only “plants produced by targeted mutagenesis and cisgenesis” [1]. Copa-Cogeca publicly comments on the proposal, welcoming “the fact that the Commission’s proposal plans exemptions from EU GMO legislation for certain specific NBTs and […]

Recently, the European Economic and Social Committee urgently adopted an opinion critical of the Commission’s plan to deregulate new GMOs/NTGs, as part of the mandatory consultation procedure. The European Committee of the Regions has also been consulted, but its opinion has not yet been published. However, in May 2023, this committee issued an opinion on […]

Recently, the European Economic and Social Committee urgently adopted an opinion critical of the Commission’s plan to deregulate new GMOs/NTGs, as part of the mandatory consultation procedure. The European Committee of the Regions has also been consulted, but its opinion has not yet been published. However, in May 2023, this committee issued an opinion on […]

At a conference organized at the European Parliament on October 26, 2023 by Socialist MEP Christophe Clergeau, the French consumer association UFC-Que Choisir, through the voice of Olivier Andrault, was clear : GMOs, whether « classical » or renamed NGT (New Genomic Techniques), must be assessed, labeled, and present real benefits, notably for the end consumer. The position […]

At a conference organized at the European Parliament on October 26, 2023 by Socialist MEP Christophe Clergeau, the French consumer association UFC-Que Choisir, through the voice of Olivier Andrault, was clear: GMOs, whether “classical” or renamed NGT (New Genomic Techniques), must be assessed, labeled, and present real benefits, notably for the end consumer. The position […]

Many additives and vitamins are now produced industrially by micro-organisms, some of them being genetically modified. The applications for authorization consulted by Inf’OGM for the latter are less numerous (122 dossiers out of 723 read) than for enzymes. But these molecules are important to know, as they are increasingly present in human and animal foodstuffs… […]

In a series of articles, Inf’OGM attempts to unravel the complex subject of genetically modified microorganisms (GMMs) and their industrial use [1]. We have already analyzed the use of these GMMs to produce enzymes used in agri-food chains [2]. Vitamins or additives, such as sweeteners or amino acids, can also be produced industrially via GMMs. Less applications […]

Inf’OGM has studied over 600 dossiers filed in the European Union for molecules (enzymes, vitamins, additives) produced by micro-organisms, whether genetically modified or not. Among these dossiers, three concern the production of molecules, attempts at synthetic copies of chemical compounds present natively in Stevia. The aim is to produce sweeteners. The three companies, Avansya, Amyris […]